C3.ai Inc vs Becton Dickinson and Co — how do they compare? C3.ai Inc trades at $10.56 (market cap $1.65B), while Becton Dickinson and Co trades at $181.29 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 29.9× C3.ai Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | BDX | |
|---|---|---|
Market Cap | $1.65B | $49.41B |
Sector | Technology | Health |
52-Week High | $19.66 | $185.39 |
52-Week Low | $7.76 | $138.62 |
Enterprise Value | $1.08B | $65.51B |
Dividend Yield | — | 2.32% |
Trailing returns across standard periods
Latest headlines on both assets
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →